We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

187 hedge funds and large institutions have $3.03B invested in Pacira BioSciences in 2015 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 73 increasing their positions, 63 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more call options, than puts

Call options by funds: $31.6M | Put options by funds: $24.3M

16% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 63

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

9% less funds holding

Funds holding: 205 → 187 (-18)

15% less capital invested

Capital invested by funds: $3.58B → $3.03B (-$553M)

34% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 47

Holders
187
Holders Change
-18
Holders Change %
-8.78%
% of All Funds
5.04%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
31
Increased
73
Reduced
63
Closed
47
Calls
$31.6M
Puts
$24.3M
Net Calls
+$7.32M
Net Calls Change
+$7.3M

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$124M
2
HCM
Hoplite Capital Management
New York
+$99.4M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$60.3M
4
Goldman Sachs
Goldman Sachs
New York
+$58.9M
5
VAM
Visium Asset Management
New York
+$48.4M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$92.5M
2
RIM
RS Investment Management
California
-$54.3M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$35.5M
4
EAM
Eagle Asset Management
Florida
-$29.5M
5
HCM
Hodges Capital Management
Texas
-$26.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
51
AWM Investment Company
New York
$7.43M +$2.76M +35,000 +50%
DCM
52
Decade Capital Management
New York
$7.07M +$7.88M +100,000 New
UBS AM
53
UBS AM
Illinois
$6.08M +$4.65K +59 +0.1%
ECP
54
Elk Creek Partners
Colorado
$5.07M +$5.65M +71,700 New
TD Asset Management
55
TD Asset Management
Ontario, Canada
$5.04M -$717K -9,100 -11%
RSCM
56
Rock Springs Capital Management
Maryland
$4.81M +$1.36M +17,250 +34%
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$4.71M +$104K +1,316 +2%
AllianceBernstein
58
AllianceBernstein
Tennessee
$4.67M -$15.3M -194,200 -75%
Morgan Stanley
59
Morgan Stanley
New York
$4.57M -$931K -11,827 -15%
CS
60
Credit Suisse
Switzerland
$4.45M +$2.6M +33,031 +110%
RJA
61
Raymond James & Associates
Florida
$4.16M -$2.83M -35,982 -38%
TA
62
Teachers Advisors
New York
$3.75M +$159K +2,023 +4%
GC
63
Guggenheim Capital
Illinois
$3.53M +$616K +7,819 +19%
GH
64
GAM Holding
Switzerland
$3.37M +$1.34M +17,000 +55%
OPPM
65
Opus Point Partners Management
New York
$3.32M +$949K +12,051 +34%
California Public Employees Retirement System
66
California Public Employees Retirement System
California
$3.27M +$112K +1,427 +3%
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$3.09M +$3.34M +42,446 +3,293%
Bank of America
68
Bank of America
North Carolina
$3.05M -$625K -7,940 -16%
Swiss National Bank
69
Swiss National Bank
Switzerland
$2.88M +$197K +2,500 +7%
PAM
70
Paradigm Asset Management
New York
$2.86M – – –
CPS
71
Counsel Portfolio Services
Ontario, Canada
$2.83M +$392K +4,979 +14%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$2.72M -$103K -1,305 -3%
PRCM
73
Pine River Capital Management
Minnesota
$2.71M +$3.02M +38,379 New
TCM
74
Tygh Capital Management
Oregon
$2.62M -$2.66M -33,821 -48%
RHJA
75
Rice Hall James & Associates
California
$2.61M +$2.91M +36,956 New
1 2
3
4 5

PCRX Hedge Fund Activity: Q2 2015 in Review

187 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q2 2015, worth a combined $3.03B — down 15% from $3.58B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of PCRX and 31 opened new positions — a net loss of 16 holders — while 63 trimmed existing stakes and 73 added.

The largest buyer was Janus Henderson Investors US, adding an estimated $124M. The largest seller was Jennison Associates, cutting an estimated $92.5M.

  • 187 institutional investors held Pacira BioSciences (PCRX) as of Q2 2015, down from 205 in Q1 2015.
  • Funds reported $3.03B of Pacira BioSciences stock for Q2 2015, down 15% quarter-over-quarter.
  • 31 funds opened new Pacira BioSciences positions in Q2 2015 and 47 closed out, a net change of -16 holders.
  • The largest Pacira BioSciences buyer in Q2 2015 was Janus Henderson Investors US, an estimated $124M added.
  • The largest Pacira BioSciences seller in Q2 2015 was Jennison Associates, an estimated $92.5M sold.

Based on aggregated 13F filings for Q2 2015.